Prucalopride - CISMeF

Preferred Label : Prucalopride;

NCIt definition : An orally bioavailable dihydro-benzofuran-carboxamide and selective serotonin (5-HT4) receptor agonist, with gastrointestinal (GI) prokinetic activity. Upon oral administration, prucalopride specifically targets, binds to and stimulates the 5-HT4 receptor. This alters colonic motility patterns and stimulates colonic mass movements. This may normalize bowel movements and may relief chronic constipation. In addition, by increasing esophageal and gastric motility, prucalopride may also provide relief for aspiration-associated symptoms.;

UNII : 0A09IUW5TP;

InChIKey : ZPMNHBXQOOVQJL-UHFFFAOYSA-N;

CAS number : 179474-81-8;

Chemical formula : C18H26ClN3O3;

Détails

Origin ID

C74386;

UMLS CUI

C0913506;

CISMeF manual mappings
- Prucalopride (substance) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing prucalopride (medicinal product) [SNOMED CT concept]
- Prucalopride (substance) [SNOMED CT concept]
- prucalopride [ATC Code]
- prucalopride [MeSH Supplementary Concept]
- prucalopride [MeSH concept]
Validated automatic mappings to BTNT
- prucalopride [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients